| 000 | 01837 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514012140.0 | ||
| 264 | 0 | _c20011204 | |
| 008 | 200112s 0 0 eng d | ||
| 022 | _a1524-4636 | ||
| 024 | 7 |
_a10.1161/hq1001.097028 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCai, H | |
| 245 | 0 | 0 |
_aInduction of endothelial NO synthase by hydrogen peroxide via a Ca(2+)/calmodulin-dependent protein kinase II/janus kinase 2-dependent pathway. _h[electronic resource] |
| 260 |
_bArteriosclerosis, thrombosis, and vascular biology _cOct 2001 |
||
| 300 |
_a1571-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzylamines _xpharmacology |
| 650 | 0 | 4 |
_aCalcium _xphysiology |
| 650 | 0 | 4 | _aCalcium-Calmodulin-Dependent Protein Kinase Type 2 |
| 650 | 0 | 4 |
_aCalcium-Calmodulin-Dependent Protein Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aCattle |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aHydrogen Peroxide _xpharmacology |
| 650 | 0 | 4 | _aJanus Kinase 2 |
| 650 | 0 | 4 |
_aNitric Oxide Synthase _xbiosynthesis |
| 650 | 0 | 4 | _aNitric Oxide Synthase Type III |
| 650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xphysiology |
| 650 | 0 | 4 | _aProto-Oncogene Proteins |
| 650 | 0 | 4 |
_aRNA, Messenger _xbiosynthesis |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_aSulfonamides _xpharmacology |
| 650 | 0 | 4 | _aTranscriptional Activation |
| 700 | 1 | _aDavis, M E | |
| 700 | 1 | _aDrummond, G R | |
| 700 | 1 | _aHarrison, D G | |
| 773 | 0 |
_tArteriosclerosis, thrombosis, and vascular biology _gvol. 21 _gno. 10 _gp. 1571-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/hq1001.097028 _zAvailable from publisher's website |
| 999 |
_c11517841 _d11517841 |
||